Nature Mental Health, Published online: 20 August 2026; doi:10.1038/s44220-026-00709-2
This Comment reviews pharmacists’ current contributions to psychiatric care in the USA and explains how their expertise, especially that of Board-Certified Psychiatric Pharmacists (BCPPs), positions them to have a key role in the safe, effective delivery of psychedelic therapies. Despite regulatory, reimbursement and training barriers, integrating BCPPs into this emerging field could improve patient safety, address workforce shortages and expand access to care.